MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

<< Previous

Bullboard Posts

Next >>

Post by august202013on Mar 14, 2023 11:50pm

193 Views

Post# 35338924

MEDMIRA HAS THEREFORE MADE AN INROADS INTO HC

That itself is a PERFECT NEWS ACTUALLY!

There are many Phases before you are allowed to market your PERFECT PRODUCT. Once it passes all stages then you can market it.

Believe for drugs/vaccine it has stage 1 a, b
Then stage 2 a, b. Believe for test kits in the medical field also has 2 stages.

All MEDMIRA long-term shareholders must be frustrated BUT believe this news TODAY will be well received by analyst and institutional investors therefore should have some positive impact on the company and its potential in clear terms PRICE should open HIGHER tomorrow. Overall is a good news.

Just have to wait and see.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal